India, Jan. 31 -- NLS Pharmaceutics AG's (NLSP) stock saw a notable increase of 29.79 percent, during Friday morning trading. This surge follows the announcement for the company a merger with Kadimastem Ltd.
Currently NLSP is trading at $2.45, up 29.79 percent or $0.475 on the Nasdaq. The stock reached a high of $3.37 and traded within a range of $2.38 to $3.37 throughout the day. Although volume information for the day remains unavailable, the average trading volume is around 1.22 million shares.
The merger, which was approved by Kadimastem's shareholders in a special general meeting held yesterday, will bring together NLS Pharmaceutics, a Swiss clinical-stage biopharmaceutical company, and Kadimastem, a clinical-stage cell therapy compa...